logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
03/06/2025
In the first quarter of Japan, capital expenditure by enterprises increased by 6.4% year-on-year, exceeding the expected 2%, and higher than the previous value of -0.2%.
Latest
2 m ago
BioNTech (BNTX.US) continued to rise by about 8.5%, closing at $122.7. The stock surged over 18% yesterday. On the news front, Pfizer announced it had reached a milestone payment agreement with BioNTech on the new generation anti-cancer drug BNT327, with a maximum milestone payment of up to $11.1 billion. In addition, Truist Securities raised BioNTech's target price from $151 to $155, maintaining a "buy" rating.
2 m ago
BioNTech continues to rise by around 8.5% and reaches a $11 billion authorization agreement with Pfizer.
3 m ago
Minister Wang Wentao meets with Australian Minister of Trade Farrer
5 m ago
Beijing North Holding (09669.HK) subscribes to $29 million financial products.
5 m ago
U.S. stock market surges | Nuclear power stocks rise Energy Fuels (UUUU.US) up more than 8%
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.